vTv Therapeutics Inc. (VTVT) stock
VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3064% below fair value
$16.23−1.06 (-6.13%)
Close on Nov 18, 2026Market cap $64.17MP/E –Yield –
vTv Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
vTv Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $36.84M, up 216600.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.43M in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $1.02M | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $2.02M | -49.6% |
| FY2021 | Dec 31, 2021 | $4.01M | -37.6% |
| FY2020 | Dec 31, 2020 | $6.41M | +132.1% |
| FY2019 | Dec 31, 2019 | $2.76M | -77.8% |
| FY2018 | Dec 31, 2018 | $12.43M | +4172.9% |
| FY2017 | Dec 31, 2017 | $291.00K | -54.1% |
| FY2016 | Dec 31, 2016 | $634.00K | +22.2% |
| FY2015 | Dec 31, 2015 | $519.00K | -66.5% |
| FY2014 | Dec 31, 2014 | $1.55M | +58.7% |
| FY2013 | Dec 31, 2013 | $976.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $36.84M | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $17.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $1.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $9.00K | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $9.00K | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $2.00M | +102.6% |
| Q4 FY2021 | Dec 31, 2021 | $9.00K | -99.9% |
| Q3 FY2021 | Sep 30, 2021 | $3.00M | +42757.1% |
| Q2 FY2021 | Jun 30, 2021 | $9.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $987.00K | +12237.5% |
| Q4 FY2020 | Dec 31, 2020 | $6.40M | +91314.3% |
| Q3 FY2020 | Sep 30, 2020 | $7.00K | -12.5% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $8.00K | -99.1% |
| Q4 FY2019 | Dec 31, 2019 | $7.00K | -99.8% |
| Q3 FY2019 | Sep 30, 2019 | $8.00K | -99.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.83M | -26.1% |
| Q1 FY2019 | Mar 31, 2019 | $921.00K | -55.4% |
| Q4 FY2018 | Dec 31, 2018 | $4.52M | +1840.8% |
| Q3 FY2018 | Sep 30, 2018 | $3.38M | +22400.0% |
| Q2 FY2018 | Jun 30, 2018 | $2.47M | +18923.1% |
| Q1 FY2018 | Mar 31, 2018 | $2.06M | +6780.0% |
| Q4 FY2017 | Dec 31, 2017 | $233.00K | +513.2% |
| Q3 FY2017 | Sep 30, 2017 | $15.00K | -60.5% |
| Q2 FY2017 | Jun 30, 2017 | $13.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $30.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $38.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $38.00K | – |
See a number that looks wrong?